Leading the Way in Life Science Technologies

GEN Exclusives

More »

Search Results for

'Takeda'
  • Biosimilars: 11 Drugs to Watch
    May 19, 2014
    ... billion (including $4.551 billion Amgen + $3.774 billion Pfizer + $0.435 billion Takeda)3 Patent status: Patents set to expire February 2015 in EU; U.S. patents set to expire ...
  • Forum Explores Cognitive Frontier
    April 15, 2014
    We are a purpose-built company," says Deborah Dunsire, M.D., Forum's new president and CEO. Prior to joining Forum, Dr. Dunsire was president and CEO of Millennium: The Takeda ...
  • Takeda, Lilly Vow to Appeal $9B Actos Verdict
    April 8, 2014
    GEN News Highlights More » April 8, 2014 Takeda, Lilly Vow to Appeal $9B Actos Verdict Takeda Pharmaceutical and Eli Lilly said they will appeal a federal jury's verdict ordering ...
  • Mersana, Takeda Team Up to Develop ADCs
    April 7, 2014
    More » April 7, 2014 Mersana, Takeda Team Up to Develop ADCs Mersana Therapeutics inked an agreement with Millennium Pharmaceuticals, a wholly-owned subsidiary of Takeda ...
  • Top R&D Spenders of 2013
    March 17, 2014
    ... R&D spending: $2.855 billion3 2012 R&D spending: $2.778 billion3 % Change: 2.8% #12. Takeda Pharmaceutical 2013 R&D spending: $3.148 billion (¥324.292 billion) 2012 R&D ...
  • Top 10 U.S. Biopharma Clusters
    March 10, 2014
    But the region is home to AbbVie and the U.S. headquarters of Japanese pharma giants Takeda Pharmaceutical and Astellas Pharma. And any region that hosts the annual BIO ...
  • Top 10 Job-Cutting Companies of 2013
    February 24, 2014
    ... 17,700 employees as of December 31, 2012. #8. Takeda Pharmaceutical Number of job layoffs disclosed: 1,500 jobs Details: Takeda executive disclosed plan for workforce reduction ...
  • Top 10 Job-Cutting Companies of 2013
    February 24, 2014
    ... 2013. See: http://www.takeda.com/investor-information/files/qr2013_q2_p02_en.pdf 7 See ... page 3. http://www.takeda.com/investor-information/files/qr2013_q3_f_en.pdf 8 See ...
  • NIH Coaxes Big Biopharma to AMP Up Drug Development
    February 4, 2014
    biopharmas include AbbVie, Biogen Idec, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson unit Janssen Research and Development, Merck & Co., Sanofi, and Takeda. ...
  • Sanford-Burnham Wins $275M Commitment toward Strategic Vision...
    January 28, 2014
    The institute said it will refine drug candidates through preclinical validation to facilitate stronger partnerships with pharmas, such as those it maintains with Takeda ...